Raub Brock Capital Management LP Zoetis Inc. Transaction History

Raub Brock Capital Management LP

  • $465 Million
  • Q3 2025

A detailed history of Raub Brock Capital Management LP transactions in Zoetis Inc. stock. As of the latest transaction made, Raub Brock Capital Management LP holds 95,001 shares of ZTS stock, worth $13.7 Million. This represents 2.99% of its overall portfolio holdings.

Number of Shares
95,001
Previous 84,468 12.47%
Holding current value
$13.7 Million
Previous $13.2 Million 5.53%
% of portfolio
2.99%
Previous 2.87%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 15, 2025
BUY
$141.13 - $159.19 $1.49 Million - $1.68 Million
10,533 Added 12.47%
95,001 $13.9 Million
Q2 2025

Jul 23, 2025
SELL
$144.41 - $170.3 $189,321 - $223,263
-1,311 Reduced 1.53%
84,468 $13.2 Million
Q1 2025

Apr 16, 2025
SELL
$156.48 - $175.67 $473,821 - $531,928
-3,028 Reduced 3.41%
85,779 $14.1 Million
Q4 2024

Jan 15, 2025
BUY
$162.24 - $194.42 $297,223 - $356,177
1,832 Added 2.11%
88,807 $14.5 Million
Q3 2024

Oct 17, 2024
SELL
$172.58 - $196.48 $108,897 - $123,978
-631 Reduced 0.72%
86,975 $17 Million
Q2 2024

Aug 06, 2024
SELL
$145.54 - $178.83 $48,901 - $60,086
-336 Reduced 0.38%
87,606 $15.2 Million
Q1 2024

Apr 18, 2024
SELL
$165.67 - $199.94 $608,008 - $733,779
-3,670 Reduced 4.01%
87,942 $14.9 Million
Q4 2023

Jan 25, 2024
SELL
$151.44 - $200.09 $3.05 Million - $4.03 Million
-20,151 Reduced 18.03%
91,612 $18.1 Million
Q3 2023

Oct 12, 2023
SELL
$167.14 - $192.77 $618,418 - $713,249
-3,700 Reduced 3.2%
111,763 $19.4 Million
Q2 2023

Jul 26, 2023
SELL
$160.94 - $186.23 $297,417 - $344,153
-1,848 Reduced 1.58%
115,463 $19.9 Million
Q1 2023

Apr 19, 2023
BUY
$145.48 - $175.02 $777,299 - $935,131
5,343 Added 4.77%
117,311 $19.5 Million
Q4 2022

Feb 13, 2023
SELL
$131.14 - $157.47 $1.24 Million - $1.49 Million
-9,483 Reduced 7.81%
111,968 $16.4 Million
Q3 2022

Oct 13, 2022
SELL
$148.29 - $182.55 $965,071 - $1.19 Million
-6,508 Reduced 5.09%
121,451 $18 Million
Q2 2022

Jul 07, 2022
SELL
$155.97 - $200.09 $607,191 - $778,950
-3,893 Reduced 2.95%
127,959 $22 Million
Q1 2022

Apr 13, 2022
SELL
$181.39 - $234.03 $4.32 Million - $5.57 Million
-23,817 Reduced 15.3%
131,852 $24.9 Million
Q3 2021

Oct 12, 2021
SELL
$189.29 - $209.69 $816,597 - $904,602
-4,314 Reduced 2.7%
155,669 $30.2 Million
Q2 2021

Jul 21, 2021
SELL
$155.9 - $187.99 $694,534 - $837,495
-4,455 Reduced 2.71%
159,983 $29.8 Million
Q1 2021

Apr 16, 2021
SELL
$144.0 - $169.39 $302,976 - $356,396
-2,104 Reduced 1.26%
164,438 $25.9 Million
Q4 2020

Jan 06, 2021
SELL
$157.07 - $174.35 $676,186 - $750,576
-4,305 Reduced 2.52%
166,542 $27.6 Million
Q3 2020

Oct 23, 2020
SELL
$137.1 - $165.37 $373,186 - $450,137
-2,722 Reduced 1.57%
170,847 $28.3 Million
Q2 2020

Jul 14, 2020
SELL
$111.92 - $142.53 $923,228 - $1.18 Million
-8,249 Reduced 4.54%
173,569 $23.8 Million
Q1 2020

Apr 21, 2020
SELL
$92.66 - $144.94 $409,371 - $640,344
-4,418 Reduced 2.37%
181,818 $21.4 Million
Q4 2019

Jan 27, 2020
SELL
$116.25 - $133.25 $2.34 Million - $2.68 Million
-20,097 Reduced 9.74%
186,236 $24.6 Million
Q3 2019

Oct 15, 2019
SELL
$112.57 - $128.43 $93,433 - $106,596
-830 Reduced 0.4%
206,333 $25.7 Million
Q2 2019

Jul 23, 2019
SELL
$97.98 - $114.28 $941,587 - $1.1 Million
-9,610 Reduced 4.43%
207,163 $23.5 Million
Q1 2019

Apr 25, 2019
BUY
$81.56 - $100.67 $496,455 - $612,778
6,087 Added 2.89%
216,773 $21.8 Million
Q4 2018

Feb 13, 2019
BUY
$79.28 - $95.27 $363,340 - $436,622
4,583 Added 2.22%
210,686 $18 Million
Q3 2018

Nov 14, 2018
SELL
$83.5 - $93.23 $112,140 - $125,207
-1,343 Reduced 0.65%
206,103 $18.9 Million
Q2 2018

Aug 14, 2018
BUY
$79.9 - $89.2 $16.6 Million - $18.5 Million
207,446 New
207,446 $17.7 Million

Others Institutions Holding ZTS

# of Institutions
2,126
Shares Held
431M
Call Options Held
1.47M
Put Options Held
1.45M
View Full List

About Zoetis Inc.

ZTS Quotes by TradingView
  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $67.5B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Raub Brock Capital Management LP Portfolio

Follow Raub Brock Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raub Brock Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Raub Brock Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email